Video

Dr Michael D'Angelica on the Necessity of Multidisciplinary Collaboration in Hepatobiliary Cancer

Michael I. D'Angelica, MD, FACS, of Memorial Sloan Kettering Cancer Center, discusses multidisciplinary care and why it is so important in hepatobiliary cancers.

Michael I. D'Angelica, MD, FACS, director of the Hepatopancreatobiliary Fellowship Program at Memorial Sloan Kettering Cancer Center, discusses multidisciplinary care and why it is so important in hepatobiliary cancers.

Transcript

Can you speak to the importance of multidisciplinary care in the treatment of hepatobiliary cancers?

When I think about the hepatobiliary guidelines, it really comes down to this idea that it truly has to be multidisciplinary. I think we say that for every cancer, and it's obvious that it's important. But in some cancers, it's really not as prominent as it is in hepatobiliary cancers, where you need the expertise of certain types of surgeons, transplant surgeons, surgical oncologists, or medical oncologists; but also a gastroenterologist to manage things like biliary obstruction, or interventional radiologists to perform intraarterial therapies and percutaneous ablation techniques. And again, these cancers really do require true multidisciplinary care, and i think it's critical that centers have all of this expertise if they're going to manage these cancers.

Related Videos
Milind Desai, MD
Masanori Aikawa, MD
Neil Goldfarb, GPBCH
Mabel Mardones, MD.
Mei Wei, MD, an oncologist specializing in breast cancer at Huntsman Cancer Institute at the University of Utah.
Alexander Mathioudakis, MD, PhD, clinical lecturer in respiratory medicine at The University of Manchester
Screenshot of Susan Wescott, RPh, MBA
Screenshot of an interview with Adam Colborn, JD
Screenshot of an interview with James Chambers, PhD
Screenshot of an interview with Megan Ehret, PharmD
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo